Reporting of cancer clinical trial adverse drug events: A RADAR report

被引：0
|
作者：
Belknap, S. M.
Georgopoulos, C. H.
Weitzman, S. A.
Qualkenbush, L.
Samaras, A. T.
McKoy, J. M.
Edwards, B. J.
Rosen, S. T.
West, D. P.
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Ctr Canc, Chicago, IL 60611 USA
[4] Northwestern Univ, Off Res Integr, Chicago, IL 60611 USA
[5] Northwestern Univ, Dept Med, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Northwestern Univ, Dept Med, Div Geriatr, Feinberg Sch Med, Chicago, IL 60611 USA
[7] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.6090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6090
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Reporting of Serious Adverse Events During Cancer Clinical Trials to the Institutional Review Board: An Evaluation by the Research on Adverse Drug Events And Reports (RADAR) Project
    Belknap, S. M.
    Georgopoulos, C. H.
    Lagman, J.
    Weitzman, S. A.
    Qualkenbush, L.
    Yarnold, P. R.
    Edwards, B. J.
    McKoy, J. M.
    Trifilio, S. M.
    West, D. P.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (12): : 1334 - 1340
  • [2] Reporting Adverse Drug Events
    Feagins, Linda A.
    Abdelsayed, George G.
    Schairer, Jason
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (09): : 1411 - 1413
  • [3] Adverse Event Reporting in Cancer Clinical Trial Publications
    Sivendran, Shanthi
    Latif, Asma
    McBride, Russell B.
    Stensland, Kristian D.
    Wisnivesky, Juan
    Haines, Lindsay
    Oh, William K.
    Galsky, Matthew D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (02) : 83 - 89
  • [4] More thoughts on the reporting of adverse events in cancer clinical trials
    Extermann, Martine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 918 - 918
  • [5] Preventing and Reporting Adverse Drug Events Pharmacovigilance for the Clinical Nurse Specialist
    O'Malley, Patricia Anne
    [J]. CLINICAL NURSE SPECIALIST, 2012, 26 (03) : 136 - 137
  • [6] REPORTING OF ADVERSE DRUG EVENTS - A KEY TO POSTMARKETING DRUG SAFETY
    RHEINSTEIN, PH
    [J]. AMERICAN FAMILY PHYSICIAN, 1992, 46 (03) : 873 - 874
  • [7] Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
    Noda, Aoi
    Sakai, Takamasa
    Tsuchiya, Masami
    Oyanagi, Gen
    Obara, Taku
    Mano, Nariyasu
    [J]. VACCINES, 2020, 8 (03) : 1 - 13
  • [8] The Importance of Physicians Identifying and Reporting Adverse Drug Events
    Gatti, Jasmine C.
    [J]. AMERICAN FAMILY PHYSICIAN, 2012, 85 (04) : 318 - 318
  • [9] Reporting adverse drug events to the Therapeutic Goods Administration
    Martin, Jennifer H.
    Lucas, Catherine
    [J]. AUSTRALIAN PRESCRIBER, 2021, 44 (01) : 2 - 3
  • [10] Impact of a 'trigger list' on reporting of adverse drug events
    Boon, G. R.
    Cavell, G. F.
    Morse, S. L.
    [J]. PHARMACY WORLD & SCIENCE, 2008, 30 (04): : 467 - 468
12345